{"id":4960,"date":"2017-06-08T11:52:37","date_gmt":"2017-06-08T10:52:37","guid":{"rendered":"http:\/\/backup.altanalaw.com\/?p=4960"},"modified":"2017-06-08T12:07:19","modified_gmt":"2017-06-08T11:07:19","slug":"dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar","status":"publish","type":"post","link":"https:\/\/backup.altanalaw.com\/ja\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar","title":{"rendered":"DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar"},"content":{"rendered":"

\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais<\/a>\u3068 English<\/a>\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p>

Paris, le 8 juin 2017 –\u00a0DLA Piper, Altana et Bennani & Associ\u00e9s ont conseill\u00e9 Sanofi\u00a0et\u00a0Eurapharma dans le cadre de la cession d’une participation majoritaire dans Maphar.<\/p>\n

DLA Piper a conseill\u00e9 Sanofi dans le cadre de la cession de 51% des titres de sa filiale marocaine Maphar \u00e0 Eurapharma, conseill\u00e9 par Altana et Bennani & Associ\u00e9s, et de la mise en place d\u2019un partenariat strat\u00e9gique entre Eurapharma et le groupe Sanofi qui vise \u00e0 acc\u00e9l\u00e9rer le d\u00e9veloppement des activit\u00e9s de Maphar sur les march\u00e9s marocain et africain.<\/p>\n

Eurapharma, filiale du groupe CFAO, est leader de la distribution de m\u00e9dicaments en Afrique et dans les Collectivit\u00e9s et Territoires d’Outre-Mer.<\/p>\n

Maphar est depuis pr\u00e8s de 65 ans un prestataire int\u00e9gral (de l’enregistrement \u00e0 la production et la distribution des sp\u00e9cialit\u00e9s pharmaceutiques) qui a la confiance de plus de 25 laboratoires internationaux dont les produits sont disponibles sur le march\u00e9 marocain.<\/p>\n

Sanofi restera un actionnaire de r\u00e9f\u00e9rence de Maphar \u00e0 hauteur de 49% et renforcera sa position de leader du march\u00e9 pharmaceutique marocain au travers de sa filiale Sanofi-Aventis Maroc, qui a r\u00e9alis\u00e9 d’importants investissements industriels, logistiques et scientifiques lors de ces derni\u00e8res ann\u00e9es.<\/p>\n

\u00a0<\/strong><\/p>\n

INTERVENANTS <\/strong><\/p>\n

C\u00e9dant :<\/strong><\/p>\n

Conseil juridique : DLA Piper<\/strong> avec Michel Frieh, associ\u00e9, et Cyrine Abdelmoula, counsel, Edouard Sarrazin, associ\u00e9, et Fayrouze Masmi-Dazi, collaboratrice senior, sur les aspects de droit de la concurrence, ainsi que Myriam Mejdoubi, counsel, sur les aspects de droit immobilier.<\/p>\n

DLA Piper \u00e0 Casablanca<\/strong> avec Christophe Bachelet, associ\u00e9, et Camilia Benani, collaboratrice, sur les aspects de droit marocain.<\/p>\n

Due diligence financi\u00e8re : Mazars <\/strong>avec Pierre Tchertoff, Reza Joomun, associ\u00e9s, et Th\u00e9ophile Redaud, senior manager.<\/p>\n

 <\/p>\n

Acqu\u00e9reur :<\/strong><\/p>\n

Conseil juridique : Altana <\/strong>avec Gilles Gaillard, associ\u00e9,\u00a0 Julie Rolet, counsel et Fr\u00e9d\u00e9ric Manin, associ\u00e9, sur les aspects de droit de la concurrence.<\/p>\n

Conseil juridique : Bennani & Associ\u00e9s \u00e0 Casablanca<\/strong> sur les aspects de droit marocain avec Mehdi Bennani et Abdellah Moustaid, associ\u00e9s, Widad Boukouraych et Inaya Abdellatif, collaboratrices.<\/p>\n

Conseil juridique : De Gaulle Fleurance et Associ\u00e9s<\/strong> avec Jean Marie Job, associ\u00e9, pour les contrats industriels et Catherine Castro, associ\u00e9e, pour les aspects de droit immobilier<\/p>\n

Due diligence financi\u00e8re : Deloitte<\/strong> avec Fr\u00e9d\u00e9rique Chenevoy, associ\u00e9 et Jawad Bencheqroun, directeur.<\/p>\n

Due diligence fiscale : Taj<\/strong> avec Arnaud Mourier, associ\u00e9\u00a0 et\u00a0 Damien Foisy d\u2019Angicourt, senior manager.<\/p>","protected":false},"excerpt":{"rendered":"

\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in […]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4960","post","type-post","status-publish","format-standard","hentry","category-medias","expertise-droit-societes-fusions-acquisitions","avocat-frederic-manin","avocat-gilles-gaillard"],"yoast_head":"\n<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:fr]DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar [:en]DLA Piper, Altana and Bennani & Associ\u00e9s advise Sanofi and Eurapharma on the sale of a majority stake in Maphar[:] - Altana\" \/>\n<meta property=\"og:description\" content=\"\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar\" \/>\n<meta property=\"og:site_name\" content=\"Altana\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-08T10:52:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-06-08T11:07:19+00:00\" \/>\n<meta name=\"author\" content=\"Altana Communication\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Altana Communication\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar\",\"url\":\"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar\",\"name\":\"[:fr]DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar [:en]DLA Piper, Altana and Bennani & Associ\u00e9s advise Sanofi and Eurapharma on the sale of a majority stake in Maphar[:] - Altana\",\"isPartOf\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#website\"},\"datePublished\":\"2017-06-08T10:52:37+00:00\",\"dateModified\":\"2017-06-08T11:07:19+00:00\",\"author\":{\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/backup.altanalaw.com\/#website\",\"url\":\"https:\/\/backup.altanalaw.com\/\",\"name\":\"Altana\",\"description\":\"Soci\u00e9t\u00e9 d'avocats \u00e0 la Cour de Paris\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/backup.altanalaw.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6\",\"name\":\"Altana Communication\",\"url\":\"https:\/\/backup.altanalaw.com\/ja\/author\/altanacomm\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:fr]DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar [:en]DLA Piper, Altana and Bennani & Associ\u00e9s advise Sanofi and Eurapharma on the sale of a majority stake in Maphar[:] - Altana","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"ja_JP","og_type":"article","og_title":"[:fr]DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar [:en]DLA Piper, Altana and Bennani & Associ\u00e9s advise Sanofi and Eurapharma on the sale of a majority stake in Maphar[:] - Altana","og_description":"\u7533\u3057\u8a33\u3042\u308a\u307e\u305b\u3093\u3001\u3053\u306e\u30b3\u30f3\u30c6\u30f3\u30c4\u306f\u305f\u3060\u4eca\u3000Fran\u00e7ais\u3068 English\u3000\u306e\u307f\u3067\u3059\u3002 For the sake of viewer convenience, the content is shown below in […]","og_url":"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar","og_site_name":"Altana","article_published_time":"2017-06-08T10:52:37+00:00","article_modified_time":"2017-06-08T11:07:19+00:00","author":"Altana Communication","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"Altana Communication","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar","url":"https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar","name":"[:fr]DLA Piper, Altana et Bennani & Associ\u00e9s conseillent Sanofi et Eurapharma dans le cadre de la cession d\u2019une participation majoritaire dans Maphar [:en]DLA Piper, Altana and Bennani & Associ\u00e9s advise Sanofi and Eurapharma on the sale of a majority stake in Maphar[:] - Altana","isPartOf":{"@id":"https:\/\/backup.altanalaw.com\/#website"},"datePublished":"2017-06-08T10:52:37+00:00","dateModified":"2017-06-08T11:07:19+00:00","author":{"@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.altanalaw.com\/medias\/dla-piper-altana-et-bennani-associes-conseillent-sanofi-et-eurapharma-dans-le-cadre-de-la-cession-dune-participation-majoritaire-dans-maphar"]}]},{"@type":"WebSite","@id":"https:\/\/backup.altanalaw.com\/#website","url":"https:\/\/backup.altanalaw.com\/","name":"Altana","description":"Soci\u00e9t\u00e9 d'avocats \u00e0 la Cour de Paris","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.altanalaw.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/backup.altanalaw.com\/#\/schema\/person\/4bdb47072f79b38f30b44735a4377af6","name":"Altana Communication","url":"https:\/\/backup.altanalaw.com\/ja\/author\/altanacomm"}]}},"_links":{"self":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/4960"}],"collection":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/comments?post=4960"}],"version-history":[{"count":8,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/4960\/revisions"}],"predecessor-version":[{"id":4970,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/posts\/4960\/revisions\/4970"}],"wp:attachment":[{"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/media?parent=4960"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/categories?post=4960"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.altanalaw.com\/ja\/wp-json\/wp\/v2\/tags?post=4960"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}